50 M.-H. Lee and T. Rosenthal: J Extra Corpor Technol 2026, 58, 43 – 50
Author contribution statement
Min-Ho Lee: Design of the study, data collection, analysis of the data, writing – original draft, reviewing, and editing. Tami Rosenthal: Writing – reviewing and editing.
Ethics approval
This project was undertaken as a quality improvement initiative at CHOP, and as such was not formally supervised by the Institutional Review Board per their policies.
References
1. Stammers AH. Monitoring controversies during cardiopulmonary bypass: how far have we come? Perfusion. 1998; 13: 35 – 43.
2. Southworth R, Sutton R, Mize S, et al. Clinical evaluation of a new in-line continuous blood gas monitor. J Extra Corpor Technol. 1998; 30:166 – 170.
3. Trowbridge CC, Vasquez M, Stammers AH, et al. The effects of continuous blood gas monitoring during cardiopulmonary bypass: a prospective, randomized study – part I. J Extra Corpor Technol. 2000; 32:120 – 128.
4. van Hoeven M, Overdevest E, Curvers J, van Heugten H. A comparison of continuous blood gas monitors during cardiopulmonary bypass LivaNova B-Capta, Terumo CDI 500, Spectrum Medical M4. Perfusion. 2023; 38:740 – 746.
5. Swan H, Sanchez M, Tyndall CM, Koch C. Quality control of perfusion: monitoring venous blood oxygen tension to prevent hypoxic acidosis. J Thorac Cardiovasc Surg. 1990; 99:868 – 872.
6. Trowbridge CC, Vasquez M, Stammers AH, et al. The effects of continuous blood gas monitoring during cardiopulmonary bypass: a prospective, randomized study – part II. J Extra Corpor Technol. 2000; 32:129 – 137.
7. Fried DW, Leo JJ, Mattioni GJ, et al. CDI blood parameter monitoring system 500 – a new tool for the clinical perfusionist. J Extra Corpor Technol. 2000; 32:25 – 30.
8. Ottens J, Tuble SC, Sanderson AJ, Knight JL, Baker RA. Improving cardiopulmonary bypass: does continuous blood gas monitoring have a role to play? J Extra Corpor Technol. 2010; 42:191 – 198.
9. Stammers AH, Mejak BL, Rauch ED, Vang SN, Viessman TW. Factors affecting perfusionists’ decisions on equipment utilization: results of a United States survey. J Extra Corpor Technol. 2000; 32:4 – 10.
10. Baker RA, Willcox TW. Australian and New Zealand perfusion survey: equipment and monitoring. J Extra Corpor Technol. 2006; 38:220 – 229.
11. Walc – zak A, Klein T, Voss J, et al. International pediatric perfusion practice: 2016 survey results. J Extra Corpor Technol. 2021; 53:7 – 26.
12. Rivers PA, Dobalian A, Germinario FA. A review and analysis of the clinical laboratory improvement amendment of 1988: compliance plans and enforcement policy. Health Care Manage R. 2005; 30:93 – 102.
13. Bennett SA, Conn CM, Gill HE, et al. Regulatory requirements for laboratory developed tests in the United States. J Immunol Methods. 2025; 537:113813.
14. Bellaiche AL, Nielsen PF, Brantlov S, Møller MB, Winterdahl M. Clinical evaluation of the accuracy and precision of the CDI 500 in-line blood gas monitor with and without gas calibration. J Extra Corpor Technol. 2011; 43:53 – 57.
15. Jonas RA, Bellinger DC, Rappaport LA, Wernovsky G, Hickey PR, Farrell DM, Newburger JW. Relation of pH strategy and developmental outcome after hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1993; 106:362 – 368.
16. Hiramatsu T, Miura T, Forbess JM, et al. pH strategies and cerebral energetics before and after circulatory arrest. J Thorac Cardiovasc Surg. 1995; 109:948 – 58.
17. du Plessis AJ, Jonas RA, Wypij D, et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 1997; 114:991 – 1001.
18. Lee MH, Gisnarian CJ, Shann KG. Improved estimation of total blood volume can provide a reliable prediction of dilutional hematocrit and oxygen delivery during cardiopulmonary bypass. J Extra Corpor Technol. 2019; 5:67 – 72.
19. Lee MH, Riley W. Shann KG Can the minimum protamine dose to neutralize heparin at the completion of cardiopulmonary bypass be significantly lower than the conventional practice? J Extra Corpor Technol. 2021; 53:170 – 176.
20. Lee MH, Riley W. Factors associated with errors in the heparin dose response test: recommendations to improve individualized heparin management in cardiopulmonary bypass. Perfusion. 2021; 36:513 – 523.
21. Altman DG, Bland JM. Improving doctors’ understanding of statistics. J R Stat Soc Ser A Stat Soc. 1991; 154:223 – 248.
22. Giavarina D. Understanding Bland Altman analysis. Biochem Med. 2015; 25:141 – 151.
23. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999; 8:135 – 160.
24. Reagor JA, Gao Z, Tweddell JS. Spectrum medical quantum or Terumo CDI 500: which device measures hemoglobin and oxygen saturation most accurately when compared to a benchtop blood analyzer? J Extra Corpor Technol. 2021; 53:181 – 185.
25. Steinfelder-Visscher J, Teerenstra S, Gunnewiek JM, Weerwind PW. Evaluation of the i-STAT point-of-care analyzer in critically ill adult patients. J Extra Corpor Technol. 2008; 40:57 – 60.
26. Indrasari ND, Wonohutomo JP, Sukartini N. Comparison of point-of-care and central laboratory analyzers for blood gas and lactate measurements. J Clin Lab Anal. 2019; 33: e22885.
27. Kantekin ÇU, Ercan M, Oğuz EF, et al. Evaluation of the i-STAT Blood Gas Analysis System in Cardiovascular Surgery. Med LabTechnol. 2018; 4:35 – 42.
28. Jawa A, Motara F, Moolla M, Laher AE. A comparative assessment of the nova stat profile prime plus Ò critical care analyzer. Cureus. 2020; 21:12.
29. Marklin GF, Bresler R, Dhar R. Point-of-care blood gas analyzers have an impact on the acceptance of donor lungs for transplantation. Scand J Clin Lab Invest. 2020; 80:623 – 629.
Cite this article as: Lee M-H & Rosenthal T. Is continuous in-line blood gas monitoring reliable during cardiopulmonary bypass when PaO 2 and PaCO 2 are calculated rather than measured?. J Extra Corpor Technol 2026, 58, 43 – 50. https:// doi. org / 10.1051 / ject / 2025051.